RAD51D and cancer: When examining only RAD51D c.620C>T, which was captured in data from both sequencing-based and genotyping-based controls, permutation analysis provided evidence for a higher frequency of this variant in all cancer cases versus all controls (p = 0.0098) and in all familial cases versus all controls (p = 0.014).